|
|
|
|
|
Detail |
| hsa-miR-146a |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. |
2006 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
Loss of mir-146a function in hormone-refractory prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
|
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
An NF-kB-sensitive microRNA-146a-mediated inflammatory circuit in Alzheimer's disease and in stressed human brain cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
A miRNA signature of prion induced neurodegeneration. |
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. |
2009 |
|
|
|
|
|
|